search for
confirm
cancel

News Center

Borui Medicine was approved in 2017 Provincial Enterprise Intellectual Property Strategy Promotion Plan Project

  • Categories:NEW
  • Author:
  • Origin:
  • Time of issue:2017-07-13 14:55
  • Views:0

Borui Medicine was approved in 2017 Provincial Enterprise Intellectual Property Strategy Promotion Plan Project

(Summary description)Recently, Borui Medicine was approved for the 2017 Jiangsu Province Intellectual Property Strategy Promotion Plan Project, which is affirmation of Borui Medicine's use of intellectual property strategy to enhance competitiveness.

  • Categories:NEW
  • Author:
  • Origin:
  • Time of issue:2017-07-13 14:55
  • Views:0
Information
1

Recently, Borui Medicine was approved for the 2017 Jiangsu Province Intellectual Property Strategy Promotion Plan Project, which is affirmation of Borui Medicine's use of intellectual property strategy to enhance competitiveness.

Provincial Enterprise Intellectual Property Strategy Promotion Plan Project is one of the measures for Jiangsu Province to cultivate intellectual property superior enterprises. It aims to promote enterprises to implement intellectual property strategies, enhance competitive advantages, give priority to supporting enterprises that use intellectual property to promote transformation and upgrading, and strategic emerging industries China's leading enterprises, high-tech enterprises or high-tech enterprises to be cultivated.

Intellectual property strategy is the core development strategy of Borui Medicine . Up to now, the company has applied for 178 invention patents and has authorized 43 of them, including 18 PCT global patents. Borui Pharmaceutical is one of the earlier batches of high-tech pharmaceutical companies that have passed the "Conformance Standard" project acceptance in Suzhou Industrial Park, and one of the first batch of enterprises to undertake high-value patent projects in Suzhou Industrial Park. The company protected intellectual property innovations in the form of intellectual property rights in a timely manner, and through the creation, use, protection and management of intellectual property rights, and the implementation of intellectual property rights strategies, it not only protected the company's core technology, but also broke The competitor's product life cycle enables the company's products to obtain better market opportunities and shares. For example: Entecavir, a new synthetic process developed by Borui Pharmaceuticals , possesses independent intellectual property rights, avoids the original research patent route, breaks the original research market monopoly, not only has obtained the first imitation in China, but also successfully challenged the patent in the United States, and obtained a 180-day market monopoly period. This patented process also won the 2016 First Prize of Scientific and Technological Progress of the Chinese Pharmaceutical Association (only two in the country).

The approval of the 2017 Jiangsu Provincial Enterprise Intellectual Property Strategy Promotion Plan project is an honor and affirmation, and it is also a spur. Borui Medicine will continue to strengthen the construction of the intellectual property system in the future, further enhance competitiveness, and become an advantageous enterprise of intellectual property.

Back to top ▲

Borui Medicine

address:

Building C25-28, 218 Xinghu Road, Suzhou Industrial Park, Jiangsu Province, China

Borui Medicine

phone:

0512-62620988

 

Borui Medicine

Fax:
0512-62551799

Copyright: Brilliant Biomedical (Suzhou) Co., Ltd. Website: CE Dongli · Suzhou Su ICP No. 18,000,014           

Copyright: Borui Biomedical (Suzhou) Co., Ltd. 

Powered by www.300.cn 

苏ICP备18000014号